ArticleFrontiers in oncology2022

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel

Qing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.